These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5164807)

  • 21. Thyrotropin-releasing hormone improves cardiovascular function in experimental endotoxic and hemorrhagic shock.
    Holaday JW; D'Amato RJ; Faden AI
    Science; 1981 Jul; 213(4504):216-8. PubMed ID: 6787704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Irreversibility in shock: role of vasoactive kinins.
    Massion WH; Blümel G
    Anesth Analg; 1971; 50(6):970-6. PubMed ID: 5316075
    [No Abstract]   [Full Text] [Related]  

  • 23. [Biological effects of endotoxins of gram-negative bacteria].
    Pantelić D; Savić J
    Vojnosanit Pregl; 1982; 39(4):293-7. PubMed ID: 7147791
    [No Abstract]   [Full Text] [Related]  

  • 24. Experimental haemorrhagic and endotoxic shock in dogs: evidence for imbalance in exchanges of water and solutes across cell membrane.
    Singh CM; Flear CT
    Br J Surg; 1969 Sep; 56(9):703. PubMed ID: 5808417
    [No Abstract]   [Full Text] [Related]  

  • 25. Septic shock in pediatrics.
    Hierro FR; Palomeque A; Calvo M; Torralba A
    Paediatrician; 1979; 8(1-2):93-108. PubMed ID: 471519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Presence of a myocardial depressant factor in patients in circulatory shock.
    Lovett WL; Wangensteen SL; Glenn TM; Lefer AM
    Surgery; 1971 Aug; 70(2):223-31. PubMed ID: 5560183
    [No Abstract]   [Full Text] [Related]  

  • 27. Role of the pancreas in the pathogenesis of circulatory shock.
    Lefer AM; Glenn TM
    Adv Exp Med Biol; 1971 Oct; 23(0):311-35. PubMed ID: 5006110
    [No Abstract]   [Full Text] [Related]  

  • 28. [Controversial problems of the pathogenesis of cardiogenic shock in myocardial infarct].
    Moiseev SG
    Klin Med (Mosk); 1973 Dec; 51(12):14-9. PubMed ID: 4591755
    [No Abstract]   [Full Text] [Related]  

  • 29. [An analysis of altered energy metabolism in hemorrhagic and endotoxin shock--experimental studies on the basis of hepatic mitochondrial activities].
    Shimahara Y
    Nihon Geka Hokan; 1982 May; 51(3):460-80. PubMed ID: 7138196
    [No Abstract]   [Full Text] [Related]  

  • 30. [Irreversible cardiac, toxic and post-hemorrhagic shock in a case ofmalignant diphtheria].
    Vellucci A; Costanzi G
    Minerva Med; 1967 Jul; 58(53):2438-44. PubMed ID: 6031296
    [No Abstract]   [Full Text] [Related]  

  • 31. Endotoxaemia in man.
    Lancet; 1972 Jun; 1(7765):1377. PubMed ID: 4113573
    [No Abstract]   [Full Text] [Related]  

  • 32. [Role of the sympathetic-adrenal and hypophyseal-adrenal systems in the pathogenesis of infectious-toxic shock in peritonitis].
    Sergeeva NA; Gel'fand BR; Makarova LD; Terekhova TV; Bagdat'ev VE
    Anesteziol Reanimatol; 1987; (5):32-5. PubMed ID: 2829660
    [No Abstract]   [Full Text] [Related]  

  • 33. Hydrogen permeability of canine gastric secretory epithelium during formation of acute superficial erosions.
    Moody FG; Aldrete JS
    Surgery; 1971 Jul; 70(1):154-60. PubMed ID: 5092111
    [No Abstract]   [Full Text] [Related]  

  • 34. Blood rheology after hemorrhage and endotoxin.
    Chien S; Usami S; Dellenback J; Magazinovic V
    Adv Exp Med Biol; 1972; 33(0):75-93. PubMed ID: 4604171
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies of myocardial oxidative enzymes during histaminic shock.
    Cho YW; Theogaraj J; Aviado DM; Bellet S
    Arch Int Pharmacodyn Ther; 1965 Dec; 158(2):314-23. PubMed ID: 4287918
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of a bioassay for endotoxin in clinical infections and in experimental vasomotor collapse.
    McGill MW; Porter PJ; Vivaldi E; Kass EH
    Antimicrob Agents Chemother (Bethesda); 1967; 7():132-6. PubMed ID: 5596134
    [No Abstract]   [Full Text] [Related]  

  • 37. [The endotoxic shock. Pathogenesis and therapy].
    Cremer H
    Arch Kinderheilkd; 1971; 182(3):209-17. PubMed ID: 4928617
    [No Abstract]   [Full Text] [Related]  

  • 38. [Mediators in shock processes: pathogenetic and therapeutic problems].
    Habermann E
    Verh Dtsch Ges Inn Med; 1971; 77():1221-9. PubMed ID: 4346177
    [No Abstract]   [Full Text] [Related]  

  • 39. Altered lung metabolism of prostaglandins during hemorrhagic and endotoxin shock.
    Fletcher JR; Ramwell PW
    Surg Forum; 1977; 28():184-6. PubMed ID: 103214
    [No Abstract]   [Full Text] [Related]  

  • 40. [The adrenergic system in pathogenesis of 2 types of experimental shock].
    Novelli GP; Marsili M; Del Mese A
    Acta Anaesthesiol; 1971; 22(1):1-29. PubMed ID: 5109624
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.